AstraZeneca Invests Rs 1.76 Billion to Expand Chennai Centre
ECONOMY & POLICY

AstraZeneca Invests Rs 1.76 Billion to Expand Chennai Centre

Global pharmaceutical major AstraZeneca on Saturday announced an investment of Rs 1.76 billion in India to expand capabilities and infrastructure at its Global Innovation & Technology Centre (GITC) in Chennai.
This new investment, the third in the past two years in India, will enhance the GITC’s capacity to reinforce its position as a leader in healthcare innovation both globally and within the country, AstraZeneca stated.
“This new investment reflects our ongoing mission to improve patient lives by embedding cutting-edge technologies into every aspect of our work. Chennai continues to evolve as a vital innovation hub, and our continued growth here demonstrates the state’s boundless potential,” said Mr Siva Padmanabhan, Managing Director of AstraZeneca India Pvt Ltd.
The investment will support the expansion of AstraZeneca’s world-class technology and innovation teams, including experts in artificial intelligence, data analytics, machine learning, data science and supply chain analytics, all aimed at transforming healthcare outcomes.
Furthermore, the initiative will accelerate the development of next-generation medicines, support digital and data-driven solutions, and foster future-ready healthcare ecosystems.
Quoting Tamil Nadu Chief Minister MK Stalin, the statement said, “This additional investment in Chennai is a testament to the state’s reputation as a centre of excellence for global innovation.” Mr Stalin added that the partnership would create skilled opportunities, promote knowledge exchange, and strengthen Tamil Nadu’s position as a preferred destination for forward-looking industries.
In addition to its innovative portfolio in specialist disease areas such as oncology, cardiovascular conditions, respiratory illnesses and rare diseases, AstraZeneca noted its strong presence in technology, global business services, and research and development in India. Including the GITC, the company employs more than 5,000 people in the country.

Global pharmaceutical major AstraZeneca on Saturday announced an investment of Rs 1.76 billion in India to expand capabilities and infrastructure at its Global Innovation & Technology Centre (GITC) in Chennai.This new investment, the third in the past two years in India, will enhance the GITC’s capacity to reinforce its position as a leader in healthcare innovation both globally and within the country, AstraZeneca stated.“This new investment reflects our ongoing mission to improve patient lives by embedding cutting-edge technologies into every aspect of our work. Chennai continues to evolve as a vital innovation hub, and our continued growth here demonstrates the state’s boundless potential,” said Mr Siva Padmanabhan, Managing Director of AstraZeneca India Pvt Ltd.The investment will support the expansion of AstraZeneca’s world-class technology and innovation teams, including experts in artificial intelligence, data analytics, machine learning, data science and supply chain analytics, all aimed at transforming healthcare outcomes.Furthermore, the initiative will accelerate the development of next-generation medicines, support digital and data-driven solutions, and foster future-ready healthcare ecosystems.Quoting Tamil Nadu Chief Minister MK Stalin, the statement said, “This additional investment in Chennai is a testament to the state’s reputation as a centre of excellence for global innovation.” Mr Stalin added that the partnership would create skilled opportunities, promote knowledge exchange, and strengthen Tamil Nadu’s position as a preferred destination for forward-looking industries.In addition to its innovative portfolio in specialist disease areas such as oncology, cardiovascular conditions, respiratory illnesses and rare diseases, AstraZeneca noted its strong presence in technology, global business services, and research and development in India. Including the GITC, the company employs more than 5,000 people in the country.

Next Story
Infrastructure Urban

VECV Sales Rise 7.8 Per Cent In May 2026

VE Commercial Vehicles recorded sales of 7,978 units in May 2026, compared to 7,401 units in May 2025, registering growth of 7.8 per cent. This included 7,789 units from the Eicher brand and 189 units from the Volvo brand.Eicher branded trucks and buses reported sales of 7,789 units during the month, up 7.3 per cent from 7,258 units a year earlier. In the domestic commercial vehicle market, Eicher sales rose 9.1 per cent to 7,375 units from 6,758 units in May 2025.Exports declined 17.2 per cent to 414 units from 500 units in the corresponding month last year. Volvo Trucks and Volvo Buses recor..

Next Story
Infrastructure Urban

Table Space Strengthens DESYN Leadership Team

Table Space has announced strategic leadership appointments within DESYN, its integrated Design and Build business, as it looks to strengthen operations across key enterprise and GCC markets in India. DESYN was launched as a strategic extension of Table Space’s workspace solutions portfolio to meet rising demand for agile, high-quality and rapidly deployable enterprise workspaces.Shruti Ookabhoy has joined DESYN as Executive Director and will lead the Design vertical, focusing on design capability, operational excellence and team development across markets. She brings over 22 years of experi..

Next Story
Infrastructure Transport

Concord Associate Bags Rs 2.79 Bn Kavach Order

Concord Control Systems said its associate company, Progota India, has received a Rs 2.79 bn domestic order from Indian Railways for the supply, installation, testing and commissioning of on-board Kavach 4.0 loco equipment.The order is scheduled for execution within 12 months and strengthens Concord’s role in India’s railway safety and signalling ecosystem. Kavach is India’s indigenous automatic train protection system, designed to improve operational safety by helping prevent signal passing at danger and reducing collision risks.Gaurav Lath, Joint Managing Director, Concord Control Syst..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement